ARSArs Technica·2hHealth
Solemnscore-0.65
As US measles cases rise, biotech firms start developing new treatments
Solemn (original framing only)
As US measles cases rise, biotech firms start developing new treatments
“Headline emphasizes rising measles cases as alarming; summary uses sarcasm ('great again') that trivializes public health threat, creating concern-driven tone.”